The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
Open Access
- 4 February 2019
- journal article
- review article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 192 (2) , 91-97
Abstract
The polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women in reproductive age with the so far undetermined causes of development. In the etiopathogenesis of PCOS, the role of insulin resistance is emphasised, which was an indication for the attempts at using chromium III salts (Cr) in augmenting pharmacotherapy applied in patients. The analysis of the usefulness and efficacy of this approach was the direct goal of this thesis. Animal tests confirmed the efficacy of chromium in maintaining the appropriate level of glycaemia and insulinaemia, normalisation of plasma concentrations of microelements and also a correlation between the Cr level, insulin and dehydroepiandrosterone (DHEA) was found. A decrease in the expression of 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase was identified in adipose tissue. Clinical studies, although sparse, show that the supplementation with chromium can improve BMI and the parameters evaluating the control of glycaemia and increase the chances for ovulation and regular menstruation. However, the small number and a variability in study protocols makes comparing them very difficult. A completely new subject that has not been yet studied is the possibility of using chromium in levelling mood disorders in patients with PCOS. Currently, there are still no sufficient proofs for introducing chromium as a standard in treating and preventing insulin resistance in patients with PCOS. However, this direction remains open, and treating insulin resistance is an important challenge in clinical practice.Keywords
Funding Information
- Akademia Wychowania Fizycznego im. Bronisława Czecha w Krakowie
This publication has 64 references indexed in Scilit:
- Epidemiology, diagnosis, and management of polycystic ovary syndromeClinical Epidemiology, 2013
- Effect of Chromium-Enriched Yeast on Fasting Plasma Glucose, Glycated Haemoglobin and Serum Lipid Levels in Patients with Type 2 Diabetes Mellitus Treated with InsulinBiological Trace Element Research, 2013
- Molecular mechanisms of chromium in alleviating insulin resistanceThe Journal of Nutritional Biochemistry, 2012
- State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)International Journal of Pediatric Endocrinology, 2011
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHuman Reproduction, 2009
- Chromium in Parenteral Nutrition: Too Little or Too Much?Gastroenterology, 2009
- A prospective, randomized clinical trial comparing chromium picolinate to metformin for the treatment of insulin resistance in obese, hispanic women with polycystic ovarian syndromeFertility and Sterility, 2007
- Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndromeFertility and Sterility, 2005
- The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic ratsJBIC Journal of Biological Inorganic Chemistry, 2002
- Chromium deficiency after long-term total parenteral nutritionDigestive Diseases and Sciences, 1986